Patritumab Deruxtecan
Drug timelines are a Plus or Pro feature.
12 regulatory and trial events tracked for Patritumab Deruxtecan, covering 2023-09-21 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) [Phase 3]